SCHEMBL30647622

SCHEMBL30647622

CCOC(=O)c1ccnc2ccc(Oc3ccccc3)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.53
MAPT P10636 5/20 0.53
LMNA P02545 4/20 0.53
L3MBTL1 Q9Y468 3/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
NMT1 P30419 4/20 0.50
KDM4E B2RXH2 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
NMT2 O60551 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
GAA P10253 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
SCN9A Q15858 1/20 0.49
TP53 P04637 1/20 0.48
MAPK1 P28482 1/20 0.48
HSP90AA1 P07900 1/20 0.47
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31510476 1.00 PTGS2 (0.53) PTGS2MAPTLMNAL3MBTL1ALDH1A1
SCHEMBL2544566 0.85 LMNA (0.68) MAPTLMNAALDH1A1HPGDNMT1
SCHEMBL621513 0.83 MAPT (0.57) PTGS2MAPTLMNAL3MBTL1ALDH1A1
SCHEMBL32684711 0.83 LMNA (0.69) LMNAALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL619012 0.82 MAPT (0.56) MAPTLMNAL3MBTL1ALDH1A1HPGD
SCHEMBL619241 0.82 NMT1 (0.58) PTGS2MAPTLMNAL3MBTL1ALDH1A1
SCHEMBL30747808 0.81 TSHR (0.58) MAPTLMNAL3MBTL1ALDH1A1HPGD
SCHEMBL11655288 0.80 KDM4E (0.59) MAPTLMNAL3MBTL1ALDH1A1HPGD
SCHEMBL29523397 0.80 NUDT1 (0.57) MAPTLMNAL3MBTL1ALDH1A1HPGD
SCHEMBL1768671 0.80 NUDT1 (0.57) MAPTLMNAL3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543878-A1 N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)- QUINOLINE-4-CARBOXAMIDES Astrazeneca AB (SE) 2025-04-30 EP disclosed
WO-2023247489-A1 N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)- QUINOLINE-4-CARBOXAMIDES ASTRAZENECA AB (SE) 2023-12-28 WO disclosed